Skip to main content
New Menu
Technology
Pharma
Clinical
Clinical Trials
Publications
About Us
Team
Press Releases
Blog
Articles
Collaborators
Videos
Careers
Portal
New Menu
Technology
Pharma
Clinical
Clinical Trials
Publications
About Us
Team
Press Releases
Blog
Articles
Collaborators
Videos
Careers
Portal
Technology
Pharma
Clinical
Overview
Clinical Trials
Publications
About Us
Overview
Team
Press Releases
Blog
Articles
Collaborators
Videos
Careers
Portal
Publications
Breadcrumb
Cellworks
Publications
PUBLICATIONS
Browse by Indication
All
Acute Myeloid Leukemia
Esophageal Cancer
Colorectal Cancer
Glioblastoma Multiforme
Head and Neck Cancer
Kidney Cancer
Liver Cancer
Melanoma
Myelodysplastic Syndrome
Non-Hodgkin Lymphoma
Non-Small Cell Lung Cancer
Pancreatic Cancer
Browse by Study Type or Conference
All
Model Validation
Clinical Validation
AACR
ASCO
ASH
WCLC
ESMO
Browse by Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
ARCHIVE
Identification of Molecular Subtypes of Thymic Epithelial Tumors and Novel Treatments Using a Computational Biological Model
Journal of Thoracic Oncology,
2018
Computational Biological Model Prediction of PD-L1 Expression and Immunotherapy Response for KRAS Mutated Lung Cancer Based on Co-Mutations
Journal of Thoracic Oncology,
2018
Genomics-driven clustering of disease-related biomarkers identifies therapeutic options in myelodysplastic syndromes (MDS)
AACR,
2018
iCare 1: A prospective clinical trial to predict treatment response based on genomics-informed computational biology in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
ASCO Annual Meeting,
2018
Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy.
BMC Cancer,
2018
A Study to Predict Response to Azacitidine or Lenalidomide/Azacitidine Combination Therapy in MDS and AML Patients Using a Computational Biological Modeling (CBM) Approach
Blood Journal,
2017
Computational Biology Approach to Predict Hypomethylating Agent (HMA) Response Using Genomic and Clinical Characteristics in Myelodsyplastic Syndromes (MDS)
Blood Journal,
2017
Sequential Azacitidine (Aza) and Lenalidomide (Len) for Patients (Pts) with Relapsed and Refractory (R/R) Acute Myeloid Leukemia (AML): Clinical Results and Predictive Modeling Using Computational Analysis and Serial Genomics
Blood Journal,
2017
Pagination
First page
« First
Previous page
‹ Previous
…
Page
4
Page
5
Page
6
Page
7
Current page
8
Page
9
Page
10
Page
11
Page
12
…
Next page
Next ›
Last page
Last »
Technology
Pharma
Clinical
Overview
Clinical Trials
Publications
About Us
Overview
Team
Press Releases
Blog
Articles
Collaborators
Videos
Careers
Portal
STAY INFORMED
Top